InsidersTradesSigma
Follow the 리센스메디컬 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 리센스메디컬 has logged 10 insider filings. Market capitalisation: €114.5bn. The latest transaction was disclosed on 30 June 2026 (Purchase). Among the most active insiders: 김건호. The full history is free.
9
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations10 total
Other
10 of 10 declarations
About 리센스메디컬
리센스메디컬 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative medical solutions.